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Abstract
Background: Atherosclerosis is an inflammatory process that develops in individuals with known risk factors that include
hypertension and hyperlipidaemia, influenced by diet. However, the interplay between diet, inflammatory mechanisms and
vascular risk factors requires further research. We hypothesised that interleukin-1 (IL-1) signaling in the vessel wall would
raise arterial blood pressure and promote atheroma.
Methodology/Principal Findings: Apoe
2/2 and Apoe
2/2/IL-1R1
2/2 mice were fed high fat diets for 8 weeks, and their blood
pressure and atherosclerosis development measured. Apoe
2/2/IL-R1
2/2 mice had a reduced blood pressure and
significantly less atheroma than Apoe
2/2 mice. Selective loss of IL-1 signaling in the vessel wall by bone marrow
transplantation also reduced plaque burden (p,0.05). This was associated with an IL-1 mediated loss of endothelium-
dependent relaxation and an increase in vessel wall Nox 4. Inhibition of IL-1 restored endothelium-dependent vasodilatation
and reduced levels of arterial oxidative stress.
Conclusions/Significance: The IL-1 cytokine system links atherogenic environmental stimuli with arterial inflammation,
oxidative stress, increased blood pressure and atherosclerosis. This is the first demonstration that inhibition of a single
cytokine can block the rise in blood pressure in response to an environmental stimulus. IL-1 inhibition may have profound
beneficial effects on atherogenesis in man.
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Introduction
Drugs to decrease plasma lipid levels and blood pressure are the
basis of the medical treatment strategy for cardiovascular disease.
Dietary modification of macronutrient and salt intakes has also
been studied with some large effects upon systolic blood pressure
in particular [1–3]. However, the exact interplay between the well-
described plaque-based inflammatory processes of atherogenesis
[2,4] and the conventional risk factors of lipids and blood pressure
remains poorly understood. We hypothesized that the pro-
inflammatory cytokine interleukin-1 (IL-1), known to have an
association with atherosclerosis, is the link between vascular
responses and high fat feeding.
In the arterial wall, IL-1 is secreted primarily by monocytes
and macrophages but also by endothelial and smooth muscle
cells [5,6]. IL-1 is an apical cytokine initiating inflammatory
signals from bacterial products, chemical injury, complement
activation and clotting factors. There are two agonistic cytokines,
IL-1a and b which both signal via the type-I IL-1 receptor (IL-
1R1). The system is tightly regulated by a natural antagonist,
interleukin-1 receptor antagonist (IL-1ra) which also binds to IL-
1R1 but does not produce a signal, and a non-signaling cell
surface receptor, IL-1 receptor type-II, which acts as a decoy at
the cell membrane or when shed as a soluble circulating decoy
receptor [7,8].
IL-1 is a powerful inflammatory stimulus to endothelial and
vascular smooth muscle cells with effects that are plausibly linked
with known mechanisms of atherogenesis [9]. Levels of IL-1 are
increased in coronary arteries affected by atherosclerosis [10,11],
and inhibition of IL-1 in animal models is associated with reduced
amounts of atheroma [12–16] as well as neointima following
angioplasty [17]. Excess IL-1 leads to vascular cell oxidative stress,
which is linked with elevation of arterial blood pressure mediated
by adverse effects of oxidative stress upon bioavailable nitric oxide.
We report here the cardiovascular effects of abolishing IL-1
signaling either by genetic deletion of IL-1R1 or by administration
of IL-1ra in proatherogenic Apoe
2/2 mice fed atherogenic diets.
We also show a link between fat feeding and blood pressure that is
mediated via IL-1 through modulation of the NADPH-oxidase
subunit 4 (Nox 4).
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More detailed methods can be found in the online supplemental
material (Text S1).
Animals
Apoe
2/2/IL-R1
2/2 mice were generated at JAX labs by cross
breeding of Apoe
2/2 (JAX 2052) with IL-R1
2/2 (JAX 3245) mice.
All mice were on a C57BL/6 background. Male mice, 8 weeks of
age, (12 per group) were fed normal chow (4.3% fat, 0.02%
cholesterol), Western diet (21% fat, 0.15% cholesterol, 0.03%
cholate, 0.296% sodium) or Western High Cholate (WHC or
Paigen) diet (18.5% fat, 0.9% cholesterol, 0.5% cholate, 0.259%
sodium) for 8 weeks. No differences in body weights between the
strains were observed either with or without fat feeding. Diets were
supplied by Special Diet Services, UK. All animal experiments
were approved by the University of Sheffield Project Review
Committee and conformed to UK Home Office ethical guidelines.
Quantification of Atherosclerotic Lesions
Histologically stained paraffin wax embedded sections were
analysed as previously described [18].
Blood Pressure Analysis
Systolic and diastolic blood pressures of mice were measured
using a Visitech tail-cuff system (Visitech Systems, NJ, USA) and
mean blood pressure calculated (supplementary text S1).
Arteriolar Myogenic Reactivity and Responsiveness to
Nitric Oxide
A pressure myograph system (Living Systems Instrumentation,
USA) was used to determine arteriolar myogenic reactivity and
responsiveness to nitric oxide, as previously described [19,20].
Bone Marrow transplantation
Irradiation and bone marrow transplantation of mice was
performed as previously described [18] (text S1).
Detection of Reactive Oxygen Species (ROS), NOS and
Nitric Oxide
Superoxide production in mouse aortic tissue sections was
detected in-situ [21]. Levels of ROS in aortic tissue were
determined by chemiluminescent assay [22]. Nitric oxide synthase
(NOS) enzymatic activity, and indirectly nitric oxide (NO)
synthesis, was measured by the conversion of 14C L-arginine to
14C L-citrulline [23]. These methods are given in detail in the
supplementary data. NO bioactivity in mice fed WHC was
determined using an enzyme immunoassay for cyclic guanosine
monophosphate (cGMP) (Cayman Chemical, UK).
Quantitative Real time polymerase chain reaction
Quantification of Nox 2 and Nox 4 was performed by
amplification of artery cDNA using a MX3000P instrument
(Stratagene) with SYBR green dye, and normalization to 18S
rRNA. For cultured cells, normalization was to b-actin. Optimized
amplification conditions were 150 mmol/L primers, 2.5 mmol/L
MgCl2, annealing at 60uC and extension at 72uC. Primer
sequences were as described in [24].
Statistical Analysis
Data groups were analyzed by t-test or one-way ANOVA
followed by a Bonferroni multiple comparison post-test, as
appropriate. Blood pressure measurements were analyzed by
global non-linear regression, followed by an F-test. Vessel
diameters were analyzed by two-way repeated-measures ANOVA.
pD2,E max, L-NAME effects and wall: lumen ratios were compared
by t-tests. Data are presented as mean6SEM. p,0.05 was
regarded as a significant difference.
Results
Further results can be found in the online supplementary text
(Results S1).
Effects of genetic deletion of IL-1R1 and diet type on
atherosclerosis lesion development
As expected, Apoe
2/2 mice fed high fat diets displayed
significant increases in atherosclerotic lesion area compared to
mice fed chow, with the Western diet with high cholate (WHC)
causing the a greatest increase (Figure 1a). In contrast, lesions
developed by Apoe
2/2/IL-R1
2/2 mice fed these high fat diets
were not significantly different to Apoe
2/2/IL-R1
2/2 mice fed on
chow. Analysis of each different diet type separately revealed no
significant difference in lesion area of Apoe
2/2 and Apoe
2/2/IL-
R1
2/2 mice fed chow (p=0.3), or Western diet (p=0.4).
However, when fed the WHC diet, Apoe
2/2/IL-R1
2/2 mice
developed a 36% smaller atherosclerotic lesion in the aortic sinus
compared to Apoe
2/2 mice (p,0.001) (Figure 1a). Representative
images of the microscopic appearance of the lesions are shown in
Figure S1. Characterisation of the lesions revealed no overt
differences with respect to strain or diet (Results S1, table S1,
Table S2, figure S2). Body weight did not differ between mice of
any group (data not shown).
Atherosclerotic lesion formation in IL-1R1 chimeric mice
fed a WHC diet
Apoe
2/2 and Apoe
2/2/IL-R1
2/2 chimeric mice were used to
determine the relative contribution of IL-1 signaling in cells
derived from the bone marrow and non-bone marrow (tissue cells)
upon the development of atherosclerosis following fat feeding.
Irradiated Apoe
2/2 mice receiving Apoe
2/2 bone marrow had
large, and Apoe
2/2/IL-R1
2/2 mice receiving Apoe
2/2/IL-R1
2/2
marrow relatively little, atherosclerosis in their aortic sinus
following 8 weeks on a WHC diet, as expected and analogous to
Apoe
2/2 and Apoe
2/2/IL-R1
2/2 non-chimeric animals.
Interestingly, Apoe
2/2 animals receiving Apoe
2/2/IL-R1
2/2
bone marrow (i.e. chimera is capable of IL-1 signaling in vessel
wall/tissue cells) did not develop a lesion that was significantly
different from Apoe
2/ mice receiving Apoe
2/2 marrow (Figure 1b).
In contrast, Apoe
2/2/IL-R1
2/2 mice receiving Apoe
2/2 bone
marrow (i.e. chimera is not able to signal via IL-1 in vessel wall/
tissue cells) developed a 1.9-fold smaller lesion than the Apoe
2/2 to
Apoe
2/2 controls (p,0.05). The lesion size between Apoe
2/2/IL-
R1
2/2 into Apoe
2/2 and Apoe
2/2 into Apoe
2/2/IL-R1
2/2 mice
also differed significantly (p,0.05) (Figure 1b).
Pathological analysis, by chromosome painting, of these animals
showed all had engrafted donor marrow (figure S3).
Blood pressure responses to fat feeding
There was no difference in mean blood pressure in Apoe
2/2/IL-
R1
2/2 mice fed the Western, WHC or chow diet (figure 2a).
However, Apoe
2/2 mice fed high fat diets had increased blood
pressure compared with chow fed animals, with WHC-fed mice
having a greater elevation than Western fed animals (p,0.05
WHC vs Western or chow)(figure 2b).
When comparing mouse strains, no difference was seen in mean
blood pressure between Apoe
2/2/IL-R1
2/2 or Apoe
2/2 fed a
IL-1 Modulates Blood Pressure
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However, on feeding high fat diets, Apoe
2/2/IL-R1
2/2 mice fed
either the Western or WHC diet had a significantly lower blood
pressure (a level comparable to Apoe
2/2 mice on chow diet) than
the Apoe
2/2 mice fed the equivalent diet (p,0.001; p,0.0001
respectively, figure 2d, 2e).
Apoe
2/2 mice on WHC diets infused with IL-1ra using an
osmotic pump also had a significantly lower blood pressure than
Apoe
2/2 mice given placebo (Figure 2f). Elevations of IL-1ra in
these animals was confirmed by ELISA, and found to be 1435.1+/
2118.7 pg/ml compared to 0.215+/20.1452 pg/ml in placebo
mice.
Effect of IL-1R1 deletion on vascular reactivity and
compliance in mice fed WHC diet
Mesenteric arteries from Apoe
2/2 and Apoe
2/2/IL-R1
2/2 mice
fed Western and WHC diets did not differ in their sensitivity to
phenylephrine (PE) (table S3). However, preconstricted arteries
from Apoe
2/2/IL-R1
2/2 mice fed these diets displayed signifi-
cantly greater vasodilator sensitivity to acetyl choline (ACh)
(p,0.05; Figures 3a and b) compared to Apoe
2/2 animals. The
vasodilatory response to ACh was also significantly different
between chow, Western and WHC diets in Apoe
2/2 mice
(p,0.05). In Apoe
2/2/IL-R1
2/2 mice fed WHC diet there was
greater constriction (19.1+/21.3%) compared to Apoe
2/2 (8.6+/
22.7%) following incubation with N(G)-nitro-L-arginine methyl
ester (L-NAME) (p=0.003), without a significant difference
between pD2 (negative logarithm of EC50: concentration required
for half maximum response) (table S3).
Both Apoe
2/2 and Apoe
2/2/IL-R1
2/2 mice demonstrated
similar internal luminal diameters of small mesenteric arteries
increased in response to increasing intraluminal pressure (active
response), with Apoe
2/2 mice fed either diet showing a trend
towards a reduced myogenic response (figure S4a, S4b). However,
only Apoe
2/2/IL-R1
2/2 mice fed WHC diet demonstrated a
greater active pressure-diameter response compared to chow fed
Apoe
2/2 mice (figure S4a).
There was no difference in the wall-to-lumen ratio (vascular
smooth muscle thickness/external diameter at 80 mmHg; h/R)
[19] between the two groups (0.115+/20.007 Apoe
2/2/IL-R1
2/2
vs 0.111+/20.011 Apoe
2/2, n=6). Endothelium-independent
relaxation responses, assessed by superfusion of sodium nitroprus-
side (SNP), also did not differ (figure 3c).
Effect of IL-1R1 deletion on NO activity, ROS, NOS and
NOX expression in mice fed WHC diet
The induction of Nox4 mRNA and generation of ROS in
response to IL-1 stimulation was confirmed in arteriolar
endothelial cells (Figure S5). ROS were not generated in response
to IL-1 in endothelial cells isolated from Apoe
2/2/IL-R1
2/2 mice
(figure S5). In contrast, Nox 4 mRNA was reduced in IL-1
stimulated vascular smooth muscle cells (VSMC) (figure S6) as
previously shown [25].
The vessel wall mechanisms that could contribute to the
observed vascular reactivity effects were investigated by examining
the expression of NO, ROS, NOS and Nox isoforms in WHC
diet-fed animals, as this diet gave the largest difference in blood
pressure and atheroma between animals with and without the
ability to signal via IL-1R1.
NO bioactivity was increased in Apoe
2/2/IL-R1
2/2 mice fed a
WHC diet compared with WHC fed Apoe
2/2 mice (n=9–11,
p,0.05) (Figure 4a). Activity of eNOS in the presence or absence
of eNOS co-factors did not differ between Apoe
2/2/IL-R1
2/2
mice fed a WHC diet compared with Apoe
2/2 mice (p=ns)
(Figure 4b). Qualitative in situ detection of ROS showed
production in atherosclerotic plaques was reduced in Apoe
2/2/
IL-R1
2/2 compared to Apoe
2/2 mice fed WHC diet (Figure 4c).
Quantitative measurement of aortic ROS production showed
ROS to be significantly reduced in Apoe
2/2/IL-R1
2/2 mice on a
WHC diet (n=9, p,0.05)(Figure 4d). ROS production was also
suppressed in Apoe
2/2 mice on a WHC diet by a 4-week infusion
Figure 1. Atherosclerosis formation in mice following feeding
of a high fat diet. Atherosclerotic lesion area in the aortic sinus of
Apoe
2/2 and Apoe
2/2/IL-R1
2/2 mice (a) and chimeric mice (b) fed a
high fat and chow diets. ApoeRDN denotes Apoe
2/2/IL-1R1
2/2 (DN)
mice receiving Apoe
2/2 bone marrow (n=3); DNRApoe denotes
Apoe
2/2 mice receiving Apoe
2/2/IL-1R1
2/2 marrow (n=9).
doi:10.1371/journal.pone.0005073.g001
IL-1 Modulates Blood Pressure
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response to feeding a high fat diet was also confirmed (figure S7).
Apoe
2/2 mice fed WHC had significantly more ROS than those
fed chow alone, with Western diet giving intermediate levels of
ROS. ROS levels were also significantly higher in Apoe
2/2/IL-
R1
2/2 mice fed WHC compared to chow (0.85+/20.14
compared to 0.51+/20.30 LU/g tissue, n=9, p,0/01).
Nox 4 expression in the whole arterial wall was significantly
reduced in Apoe
2/2/IL-R1
2/2 mice fed the WHC diet compared
to Apoe
2/2 mice (Figure 5a). Expression of Nox 1 and 2 however,
did not differ between these two mouse strains on this diet
(figure 5b, 5c).
Discussion
The Apoe
2/2 mouse fed a high fat diet is an established model of
atherogenesis. On a Western or a Western high cholate diet
(WHC, sometimes called the Paigen diet), Apoe
2/2 mice develop
aortic atheroma [26] and blood pressure is known to rise within 1
to 3 months of feeding. We show here that IL-1 inhibition reduces
atheroma formation and prevents the associated rise in blood
pressure in Apoe
2/2 mice fed high fat diets.
IL-1 inhibition was achieved by generating mice deficient for
both Apoe and IL-1 receptor 1 (IL-1R1) genes. As expected, aortic
atheroma was significantly reduced in Apoe
2/2/IL-R1
2/2 mice
Figure 2. Blood pressure of mice following feeding of a high fat diet. Mean blood pressure in Apoe
2/2/IL-1R1
2/2 (a) and Apoe
2/ (b) mice fed
all 3 diets, and Apoe
2/2/IL-1R1
2/2 compared to Apoe
2/2 mice fed chow (c) Western (d) and WHC (e). (f) Mean blood pressure in Apoe
2/2 mice
administered with hrIL-1ra or placebo, fed WHC diet. n=4 for all groups.
doi:10.1371/journal.pone.0005073.g002
IL-1 Modulates Blood Pressure
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2/2 controls. This is in agreement
with previous studies that showed decreased atherosclerosis in IL-
1b
2/2 and IL-1a
2/2 mice fed a high cholate diet [27] and with
data from a heterozygote Apoe
2/2 model [16]. In addition, both
high fat diets were associated with increased markers of
inflammation that were attenuated in Apoe
2/2/IL-1R1
2/2 mice
(Results S1). Interestingly, IL-1b and IL-1ra plasma levels in mice
were not changed in response to fat-feeding, This was not
unexpected: mature plasma IL-1b is a difficult parameter to
interpret as a non-secreted protein and IL-1ra behaves as an acute
phase reactant with a large variation in levels [28]. Any true
changes in inflammatory markers are more likely to occur locally
within the vessel wall itself.
Apoe
2/2 mice fed a high fat diet display a rise in blood pressure
that is not seen in Apoe
2/2/IL-R1
2/2 mice fed equivalent diets.
The specificity of this was confirmed by abolition of the fat-feeding
induced blood pressure rise in Apoe
2/2 mice given IL-1ra. Stroke-
prone spontaneously hypertensive rats (SHRSP) showed no
difference in blood pressure if given IL-1ra (data not shown),
suggesting that IL-1ra does not act as a non-specific vasodilator.
To study the mechanism of the attenuation of the blood
pressure rise in the Apoe
2/2/IL-R1
2/2 mice we investigated active
arteriolar pressure-diameter responses and basal and agonist-
induced NO production in Apoe
2/2 and Apoe
2/2/IL-R1
2/2 fat-
fed mice. The greater vessel diameter in response to increasing
pressure in vessels from Apoe
2/2/ILR1
2/2, together with no
observed difference in sensitivity to PE between groups or in
vascular smooth muscle constriction for the given degree of muscle
shortening (wall: lumen ratio), as well as the preserved response to
SNP, all suggest a specific endothelial response.
The strikingly preserved agonist-induced NO dependent
vasodilatation of resistance vessels from Apoe
2/2/IL-1R1
2/2 mice
compared to Apoe
2/2 in both diet groups as well as the greater
contraction in response to L-NAME in the fat-fed Apoe
2/2/IL-
1R1
2/2 mice indicate a fundamental increase in bioavailable
vessel wall nitric oxide as a result of selective loss of IL-1 signaling.
This is emphasised by the observed increase in basal cGMP
production seen in these mice. The activity of eNOS, in the
presence or absence of eNOS co-factors, did not differ between the
two mouse strains suggesting that the difference in bioavailable
NO attributable to selective IL-1 inhibition is mediated by
increased consumption of NO via increased arterial oxidative
stress.
In support of these data, there was consistent reduction of
arterial ROS levels in mice unable to signal via IL-1. Investigation
of Nox isoforms, known to regulate NADPH activity [29,30],
indicated a Nox-4 selective rise in response to fat feeding in the
Apoe
2/2 mouse attenuated by abolition of IL-1 signaling. Taken
together, these results suggest a central role for IL-1 in modulating
the blood pressure response to high lipids and that this is via a
selective reduction in bioavailable nitric oxide.
The chimeric mouse experiments were conducted to examine
the compartment in which IL-1 signaling was important. Only in
chimeras where tissue cells were unable to signal via IL-1 was a
there a decrease in atherosclerotic lesion size. These data
complement a recent study by Kamari et al. who showed reduced
atherosclerosis in wild type, WHC-fed mice reconstituted with
either IL-1b
2/2 or IL-1a
2/2 bone marrow [27].
We also demonstrate that vessel wall ROS production and Nox 4
levels are altered between the non-chimeric Apoe
2/2 and Apoe
2/2/
Figure 3. Vascular reactivity of arterioles from Apoe
2/2 and
Apoe
2/2/IL-R1
2/2 mice. (a–b) % maximum dilation of pre-constricted
mesenteric arterioles (EC80PE) to acetylcholine. (c) Endothelium-
independent relaxation responses assessed by superfusion of sodium
nitroprusside (SNP) were not different between Apoe
2/2 and Apoe
2/2/
IL-R1
2/2 mice both fed a WHC diet (n=6 per group).
doi:10.1371/journal.pone.0005073.g003
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2/2 strains on high fat diets. The myography experiments
also suggest a selective endothelial loss of function. Thus, the
data presented here add to the hypothesis that IL-1 signaling
within the blood vessel wall cells is the mechanism involved in the
blood pressure and atherogenic responses to fat feeding in Apoe
2/2
mice.
Our studies examined the effects of two different pro-
atherogenic diets, administered for 8 weeks. Of these diets, the
WHC diet is known to be the most aggressive, giving a chronic
inflammatory response compared to the acute response of a
standard Western (high cholesterol/low cholate) diet [31]. Besides
being a normal component of bile in vertebrates, cholate (E1000)
is an emulsifier and foam stabilizing agent used in food
manufacturing which leads to very high circulating cholesterol
concentrations in plasma. Given the difference in plasma
cholesterol load, it is interesting that the poor vascular reactivities
of vessels from mice fed both diets were similar with a clear gain of
function seen in mice lacking the ability to signal via IL-1R1,
irrespective of the cholate content. Atheroma development and
blood pressure elevation were graded in magnitude through chow
to the Western and WHC diets, with the WHC having the greatest
effect. In keeping with this, the greatest level of attenuation of
biological events by IL-1 inhibition was seen in the WHC diet fed
animals. These all suggest a specificity of IL-1 in the mediation of
fat fed vascular events.
The WHC diet can cause intense metabolic disruption, hepatic
dysfunction and inflammatory activation. We did not see these
effects. Additionally, we saw similar index data (e.g. blood pressure
and atheroma formation) for mice fed on the Western and the
WHC diet, though the magnitude of the blood pressure effects was
reduced with the Western diet. We feel, therefore, that where we
have used the WHC diet for further detailed experimentation that
this is justified and that the results derived are the result of
elevation in cholesterol: the Western diet giving intermediate
cholesterol levels and intermediate phenotype, and the WHC diet
giving rise to high cholesterol and an advanced phenotype.
There is considerable interest in harnessing knowledge of basic
inflammatory mechanisms of atherogenesis for therapeutic benefit.
We show that dietary manipulation in a murine model of
atherosclerosis is associated with a rise in blood pressure, an effect
attenuated by selective inhibition of a single cytokine. High fat
diets may be particularly linked with elevation in blood pressure
Figure 4. NO activity, ROS and NOS expression in mice fed WHC diet. (a) cGMP in lung homogenates (n=14), (b) eNOS enzymatic activity
(n=6) and (c) in-situ ROS (white arrowhead) in Apoe
2/2/IL-R1
2/2 and Apoe
2/2 mice fed WHC. (Note: images chosen illustrate ROS levels not
atherosclerotic lesion size). Chemiluminescent quantification of ROS in mice fed WHC (d) and Apoe
2/2 mice fed WHC diet (n=9) and administered
hrIL-1ra (n=4) (e).
doi:10.1371/journal.pone.0005073.g004
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standard Western diet to those lower in fat, but which are
isocaloric and balanced for sodium content, or which are
supplemented with omega-3 fatty acids, also lower blood pressure
[1,33–35]. Omega-3 fatty acids have also been shown to reduce
cyclooxygenase-2 and NADPH oxidase activity [36], both of
which are induced by IL-1. This suggests that the link between diet
and blood pressure may be through the IL-1 cytokine system, and
may indicate a role for IL-1 inhibition in the control of
hypertension in man.
In our experiments, there was a concomitant reduction in blood
pressure and atheroma development. In fat-fed Apoe
2/2 mice,
development of atheroma is not driven directly by the rise in blood
pressure [37]. It seems likely therefore, that the IL-1 mediated
increase in ROS and decreased NO production are the central
mechanism of atheroma development as both of these have
individually been implicated in atherogenesis. The absence of
difference in lipid levels between the different mouse strains on the
same diets (results S1) confirms the likely effect of IL-1 inhibition
on atherogenesis being a ROS/NO-based mechanism.
These data raise the possibility of an entirely novel strategy for
prevention of atherosclerosis. An anti-IL-1 based approach would
be expected to have a beneficial effect upon atherogenic
mechanisms at multiple levels. Indeed, very recent data have
indicated a beneficial effect of IL-1ra upon patients with type II
diabetes [38], ventricular function [39] and myocardial infarction
in mice [40] and a similar approach might allow mitigation of the
atherogenic potential of Western diets. We anticipate that targeted
pharmacological intervention to inhibit IL-1 in man will be
beneficial in preventing atheroma development and the clinical
consequences that arise from this important disease of developed
nations.
Supporting Information
Text S1 Expanded methods.
Found at: doi:10.1371/journal.pone.0005073.s001 (0.04 MB
DOC)
Results S1 Additional data
Found at: doi:10.1371/journal.pone.0005073.s002 (0.04 MB
DOC)
Figure S1 Microscopic appearances around the aortic sinus of
ApoE
2/2 mice fed chow, Western, and WHC compared with
ApoE
2/2/IL-1R1
2/2 mice. Original magnification62.
Found at: doi:10.1371/journal.pone.0005073.s003 (1.18 MB TIF)
Figure S2 Modulation of IL-1 signaling decreases acute phase
reactant serum amyloid A (SAA) levels. SAA was elevated in
Apoe
2/2 mice on both high fat diets, an increase that was
significantly reduced in the Apoe
2/2/IL-R1
2/2 mice on
equivalent diets. (n=9–20)
Found at: doi:10.1371/journal.pone.0005073.s004 (4.80 MB TIF)
Figure S3 Chromosome painting of bone-marrow transplanted
mice. No Y-chromosomes were seen in male mice transplanted
with female bone marrow, confirming engraftment was successful.
Male recipients of male bone marrow all have Y-chromosomes, as
expected, as a positive control for this method.
Found at: doi:10.1371/journal.pone.0005073.s005 (2.45 MB TIF)
Figure S4 Vascular reactivity of arterioles from Apoe
2/2 and
Apoe
2/2/IL-R1
2/2 mice. Intraluminal arteriolar diameter
in response to increasing pressure (0–120 mmHg). *P,0.05
Apoe
2/2/IL-R1
2/2 (n=6) and **P,0.05 Apoe
2/2 WHC
(n=6) versus Apoe
2/2 chow (n=4).
Figure 5. Nox expression following feeding of WHC diet.
Expression of Nox is selectively reduced in Apoe
2/2/IL-R1
2/2 mice fed
WHC. (a) qRT-PCR shows reduced (p,0.05) levels of Nox 4 in the
vascular wall of Apoe
2/2/IL-R1
2/2 mice fed WHC diet. Levels of Nox 2
(b) and Nox 1 (c) do not differ. n=12 per group.
doi:10.1371/journal.pone.0005073.g005
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Figure S5 ROS and Nox 4 expression in endothelial cells in
culture. Increased ROS are seen following IL-1b stimulation of
endothelial cells isolated from Apoe
2/2 mice (n=6) (a) and
human coronary endothelial cells (hCAEC) (n=6) (b). However,
no increase in ROS are seen in ECs isolated from Apoe
2/2/IL-
1R1
2/2 mice (n=6) (a). Nox 4 mRNA expression is increased in
hCAEC stimulated with IL-1b (n=5) (c).
Found at: doi:10.1371/journal.pone.0005073.s007 (9.90 MB TIF)
Figure S6 ROS and Nox 4 expression in vascular smooth
muscle cells in culture. No significant difference in ROS are seen
following IL-1b stimulation of VSMCs (n=6) (a). Nox 4 mRNA
expression is decreased in VSMC stimulated with IL-1b (n=1) (b).
Found at: doi:10.1371/journal.pone.0005073.s008 (0.30 MB TIF)
Figure S7 ROS generation in Apoe
2/2 mice following feeding
of a high fat diet. Mice fed WHC had significantly more ROS than
those fed chow alone, with Western diet giving intermediate levels
of ROS. (n=9).
Found at: doi:10.1371/journal.pone.0005073.s009 (2.79 MB TIF)
Table S1 Lipid, glucose and ALT levels in ApoE
2/2/IL-1R1
2/2
and ApoE
2/2 mice fed chow, Western High Cholate (WHC), and
Western diets. Data represents mean+/2SEM.
Found at: doi:10.1371/journal.pone.0005073.s010 (0.05 MB
DOC)
Table S2 Plasma levels of IL-1ra, IL-1b, IL-1a and IL-6 in
ApoE
2/2/IL-1R1
2/2 and ApoE
2/2 mice fed chow, Western
high cholate (WHC), and Western diets, determined by ELISA.
Data represents mean+/2SEM.
Found at: doi:10.1371/journal.pone.0005073.s011 (0.04 MB
DOC)
Table S3 Potency and efficacy of vasoconstrictor response to
phenylephrine in pressurised mesenteric arterioles from Apoe
2/2/
IL1R1
2/2 and Apoe
2/2 mice fed a Western high cholate (WHC),
Western, or Apoe
2/2 mice fed chow diet, assessed by pD2
(negative logarithm of EC50: concentration required for half
maximum response) and Emax (percentage maximum constric-
tion). All data are means+SEM. p=ns.
Found at: doi:10.1371/journal.pone.0005073.s012 (0.04 MB
DOC)
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